Isolated Lymphocytic Infiltration of Pituitary Stalk Preceding the Diagnosis of Germinoma in 2 Prepubertal Children Treated with Growth Hormone

Hormone Research

Volumn 72, Issue 1, 2009, Pages 57-62

  Edouard, T ^a   Stafford, D E J ^b   Oliver, I ^a   Jesuran, M ^a   Bertozzi, A I ^a   Cances, C ^a   Boetto, S ^c   Guilbeau Frugier, C ^d   Delisle, B ^d   Tauber, M ^a  

^a HÔPITAL DES ENFANTS   (France)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c CHU PURPAN   (France)

^d CHU RANGUEIL   (France)

Author keywords

Diabetes insipidus; Germinoma; Growth hormone treatment; Lymphocytic hypophysitis; Panhypopituitarism

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; ARGIPRESSIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; DESMOPRESSIN; DIPEPTIDYL CARBOXYPEPTIDASE; GADOLINIUM; GROWTH HORMONE; LEVOTHYROXINE;

ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHILD; CLINICAL FEATURE; DIABETES INSIPIDUS; DISEASE COURSE; ENDOSCOPIC BIOPSY; FEMALE; FOLLOW UP; GERM CELL TUMOR; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; HYPOPITUITARISM; HYPOTHYROIDISM; INFUNDIBULUM; LYMPHOCYTIC INFILTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR GROWTH;

CHILD; CHILD, PRESCHOOL; DEAMINO ARGININE VASOPRESSIN; DIABETES INSIPIDUS, NEUROGENIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; GERMINOMA; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; LYMPHOCYTES; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY GLAND; PITUITARY GLAND, ANTERIOR; THYROXINE;

EID: 67651119942     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000224342     Document Type: Article

References (23)

1. Leger J, Velasquez A, Garel C, Hassan M, Czernichow P: Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. J Clin Endocrinol Metab 1999;84:1954-1960.
2. Bettendorf M, Fehn M, Grulich-Henn J, Selle B, Darge K, Ludecke DK, Heinrich UE, Saeger W: Lymphocytic hypophysitis with central diabetes insipidus and consequent panhypopituitarism preceding a multifocal, intracranial germinoma in a prepubertal girl. Eur J Pediatr 1999;158:288-292.
3. Mikami-Terao Y, Akiyama M, Yanagisawa T, Takahashi-Fujigasaki J, Yokoi K, Fukuoka K, Sa kuma M, Miyat a I, Fujisawa K, Oi S, Eto Y: Lymphocytic hypophysitis with central diabetes insipidus and subsequent hypopituita-rism masking a suprasellar germinoma in a 13-year-old girl. Childs Nerv Syst 2006;22:1338-1343.
4. Cemeroglu AP, Blaivas M, Muraszko KM, Robertson PL, Vazquez DM: Lymphocytic hypophysitis presenting with diabetes insip-idus in a 14-year-old girl: case report and review of the literature. Eur J Pediatr 1997;156:684-688.
5. Younes JS, Secord EA: Panhypopituitarism in a child with common variable immunodeficiency. Ann Allergy Asthma Immunol 2002;89:322-325.
6. Papathanasiou A, Kousta E, Skarpa V, Pa-pachileos P, Petrou V, Hadjiathanasiou C: Growth hormone deficiency in a patient with autoimmune polyendocrinopathy type 2. Hormones (Athens) 2007;6:247-250.
7. Walker AH, Ross RK, Haile RW, Henderson BE: Hormonal factors and risk of ovarian germ cell cancer in young women. Br J Cancer 1988;57:418-422.
8. Kato T, Sawamura Y, Tada M, Murata J, Abe H, Shirato H, Fujieda K: Occult neurohy-pophyseal germinomas in patients presenting with central diabetes insipidus. Neuro-surg Focus 1998;5:e6.
9. Mootha SL, Barkovich AJ, Grumbach MM, Edwards MS, Gitelman SE, Kaplan SL, Conte FA: Idiopathic hypothalamic diabetes in-sipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents. J Clin Endocrinol Metab 1997;82:1362-1367.
10. Pomarede R, Czernichow P, Finidori J, Pfister A, Roger M, Kalifa C, Zucker JM, Pierre-Kahn A, Rappaport R: Endocrine aspects and tumoral markers in intracranial germinoma: an attempt to delineate the diagnostic procedure in 14 patients. J Pediatr 1982;101:374-378.
11. Sklar CA, Grumbach MM, Kaplan SL, Conte FA: Hormonal and metabolic abnormalities associated with central nervous system germinoma in children and adolescents and the effect of therapy: report of 10 patients. J Clin Endocrinol Metab 1981;52:9-16.
12. Jenkins PJ, Mukherjee A, Shalet SM: Does growth hormone cause cancer? Clin Endo-crinol (Oxf) 2006;64:115-121.
13. Colao A, Ferone D, Marzullo P, Lombardi G: Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004;25:102-152.
14. Allen DB, Rundle AC, Graves DA, Blethen SL: Risk of leukemia in children treated with human growth hormone: review and reanalysis. J Pediatr 1997;131:S32-S36.
15. Nishi Y, Tanaka T, Takano K, Fujieda K, Igarashi Y, Hanew K, Hirano T, Yokoya S, Tachibana K, Saito T, Watanabe S: Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan. GH Treatment Study Committee of the Foundation for Growth Science, Japan. J Clin Endocrinol Metab 1999;84:1961-1965.
16. Tuffli GA, Johanson A, Rundle AC, Allen DB: Lack of increased risk for extracranial, nonleukemic neoplasms in recipients of re-combinant deoxyribonucleic acid growth hormone. J Clin Endocrinol Metab 1995;80:1416-1422.
17. Swerdlow AJ, Higgins CD, Adlard P, Preece MA: Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohor tstudy. Lancet 2002;360:273-277.
18. Swerdlow AJ, Reddingius RE, Higgins CD, Spoudeas HA, Phipps K, Qiao Z, Ryder WD, Brada M, Hayward RD, Brook CG, Hindmarsh PC, Shalet SM: Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J Clin Endocrinol Metab 2000;85:4444-4449.
19. Packer RJ, Boyett JM, Janss AJ, Stavrou T, Kun L, Wisoff J, Russo C, Geyer R, Phillips P, Kieran M, Greenberg M, Goldman S, Hy-der D, Heideman R, Jones-Wallace D, August GP, Smith SH, Moshang T: Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control. J Clin Oncol 2001;19:480-487.
20. Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y, Robison LL: Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002;87:3136-3141.
21. Darendeliler F, Karagiannis G, Wilton P, Ranke MB, Albertsson-Wikland K, Anthony Price D;on behalf of the KIGS International Board: Recurrence of brain tumours in patients treated with growth hormone: ana lysis of KIGS (Pfizer International Growth Database). Acta Paediatr 2006;95:1284-1290.
22. Chung TT, Drake WM, Evanson J, Walker D, Plowman PN, Chew SL, Grossman AB, Bes-ser GM, Monson JP: Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement. Clin Endocrinol (Oxf) 2005;63:274-279.
23. Uchino Y, Saeki N, Iwadate Y, Yasuda T, Konda S, Watanabe T, Wada K, Kazukawa I, Hi-guchi Y, Iuchi T, Tatsuno I, Yamaura A: Recurrence of sellar and suprasellar tumors in children treated with hGH - relation to im-munohistochemical study on GH receptor. Endocr J 2000;47(suppl):S33-S36.